HealthEquity (NASDAQ:HQY) Given New $105.00 Price Target at Barrington Research

HealthEquity (NASDAQ:HQYFree Report) had its target price upped by Barrington Research from $100.00 to $105.00 in a report issued on Tuesday morning, Benzinga reports. Barrington Research currently has an outperform rating on the stock.

HQY has been the topic of several other reports. Barclays boosted their price objective on HealthEquity from $84.00 to $104.00 and gave the stock an overweight rating in a research note on Friday, February 23rd. KeyCorp boosted their price target on HealthEquity from $85.00 to $95.00 and gave the company an overweight rating in a report on Friday, March 22nd. Robert W. Baird boosted their price target on HealthEquity from $98.00 to $104.00 and gave the company an outperform rating in a report on Tuesday. BTIG Research upped their target price on HealthEquity from $100.00 to $110.00 and gave the stock a buy rating in a report on Wednesday, March 20th. Finally, JPMorgan Chase & Co. upped their target price on HealthEquity from $86.00 to $108.00 and gave the stock an overweight rating in a report on Tuesday, April 2nd. One analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus price target of $100.17.

View Our Latest Stock Report on HQY

HealthEquity Stock Performance

HQY stock opened at $83.40 on Tuesday. The company has a market cap of $7.26 billion, a P/E ratio of 130.31, a price-to-earnings-growth ratio of 1.19 and a beta of 0.55. HealthEquity has a 1 year low of $57.97 and a 1 year high of $85.71. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. The stock’s fifty day moving average price is $79.57 and its 200-day moving average price is $76.01.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The business had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. On average, equities analysts forecast that HealthEquity will post 2.12 earnings per share for the current year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Evelyn S. Dilsaver sold 32,500 shares of HealthEquity stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total value of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares in the company, valued at $2,547,032.67. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the transaction, the chief executive officer now directly owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the sale, the director now owns 32,123 shares in the company, valued at $2,547,032.67. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Hedge funds have recently made changes to their positions in the business. Rise Advisors LLC bought a new stake in shares of HealthEquity in the 1st quarter worth about $28,000. Cape Investment Advisory Inc. acquired a new position in shares of HealthEquity in the 4th quarter valued at about $27,000. McGlone Suttner Wealth Management Inc. acquired a new position in HealthEquity during the 4th quarter valued at about $29,000. YHB Investment Advisors Inc. acquired a new position in HealthEquity during the 1st quarter valued at about $40,000. Finally, Fidelis Capital Partners LLC bought a new stake in shares of HealthEquity during the 1st quarter worth about $42,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.